糖皮质激素所致生长障碍研究新进展

来源 :中华内分泌代谢杂志 | 被引量 : 0次 | 上传用户:keiryu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
糖皮质激素是多种儿科疾病的重要治疗药物,其对骨骼系统的不良反应主要表现在三方面:骨质疏松、股骨头坏死和生长障碍。其中糖皮质激素所致的生长障碍导致终身高降低,是儿童患者治疗中需格外关注的问题。糖皮质激素引起生长障碍的机制复杂,且目前没有安全有效的治疗方法。本文总结了有关糖皮质激素抑制纵向骨生长的机制,并对近年来发现的潜在治疗靶点进行综述。“,”Glucocorticoid is an important treatment for many pediatric diseases and it often leads to osteoporosis, osteonecrosis of the femoral head, and growth retardation. Among them, glucocorticoid-induced growth retardation has been a particular focus in the treatment of children patients, which leads to a decrease in final height. The mechanism of glucocorticoid-induced growth retardation is complex, and there is no safe and effective treatment.This article summarized the mechanisms underlying glucocorticoid-inhibited longitudinal bone growth and reviewed the potential therapeutic targets discovered in recent years.
其他文献
目的:探讨海南百岁老人糖尿病的分布特征及影响因素。方法:研究对象来自中国海南百岁老人队列研究,共1 002名百岁老人纳入分析。参考糖尿病防治指南的诊断标准,根据FPG水平和既